propagermanium has been researched along with Arteriosclerosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eto, Y; Fuchigami, M; Ishiwata, Y; Matsushima, K; Morishige, K; Shimokawa, H; Takeshita, A; Tanaka, E | 1 |
Wakabayashi, Y | 1 |
Hirata, K; Inoue, N; Kawashima, S; Namiki, M; Ozaki, M; Yamashita, T; Yokoyama, M | 1 |
3 other study(ies) available for propagermanium and Arteriosclerosis
Article | Year |
---|---|
Long-term treatment with propagermanium suppresses atherosclerosis in WHHL rabbits.
Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Cell Line; Germanium; Humans; Organometallic Compounds; Propionates; Rabbits; Receptors, CCR2; Receptors, Chemokine; Receptors, LDL | 2003 |
Effect of germanium-132 on low-density lipoprotein oxidation and atherosclerosis in Kurosawa and Kusanagi hypercholesterolemic rabbits.
Topics: Aging; Animals; Anticholesteremic Agents; Aorta, Thoracic; Arteriosclerosis; Female; Germanium; Hypercholesterolemia; Kinetics; Lipoproteins, LDL; Organometallic Compounds; Oxidation-Reduction; Oxidative Stress; Propionates; Rabbits; Thiobarbituric Acid Reactive Substances | 2001 |
Propagermanium reduces atherosclerosis in apolipoprotein E knockout mice via inhibition of macrophage infiltration.
Topics: Abdomen; Animals; Apolipoproteins E; Arteriosclerosis; Cell Adhesion; Cell Line; Cell Migration Inhibition; Cells, Cultured; Chemokine CCL2; Cholesterol, Dietary; Endothelium, Vascular; Female; Germanium; Lipids; Macrophage Activation; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Organometallic Compounds; Propionates; Thioglycolates | 2002 |